The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2007 - 2011
PUBLICATIONS DURING THE PHD PROGRAM
- Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.
Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr.
Peptides. 2008 Nov;29(11):1878-86. - Leptin signaling in breast cancer: an overview.
Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N.
J Cell Biochem. 2008 Nov 1;105(4):956-64. Review - The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Rossi A, Russo G, Puca A, La Montagna R, Caputo M, Mattioli E, Lopez M, Giordano A, Pentimalli F.
Int J Cancer. 2009 Jul 1;125(1):235-43. - New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.
Rossi A, Schenone S, Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, Puca A, Pucci B, La Montagna R, Bologna M, Botta M, Giordano A.
FASEB J. 2010 Aug;24(8):2881-92. Epub 2010 Mar 30. - Adenosine receptor ligands in clinical trials.
Rizzolio F, La Montagna R, Tuccinardi T, Russo G, Caputi M, Giordano A.
Curr Top Med Chem. 2010;10(10):1036-45.
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
ACTIVITY DURING THE PHD PROGRAM
TRAINING PERIOD ABROAD
- Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA
2010: twelve months